S. Parikh Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 4.53 M
as on 07-07-2024
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.60 Cr
as on 07-07-2024
- Satisfied Charges ₹ 10.10 Cr
as on 07-07-2024
- Revenue -2.01%
(FY 2023)
- Profit -8.93%
(FY 2023)
- Ebitda -77.80%
(FY 2023)
- Net Worth 17.56%
(FY 2023)
- Total Assets 8.49%
(FY 2023)
About S. Parikh Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 4.53 M.
The company currently has active open charges totaling ₹11.60 Cr. The company has closed loans amounting to ₹10.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ankit Shah, Bhaumik Shah, Ashwin Shantilal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2008PTC187415
- Company No.
187415
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Oct 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at S. Parikh Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhaumik Shah  | Director | 16-Apr-2009 | Current |
| Ankit Shah | Director | 18-Feb-2016 | Current |
| Ashwin Shantilal | Director | 16-Apr-2009 | Current |
| Nemish Rajesh | Director | 05-Sep-2011 | Current |
| Nikesh Parekh | Director | 16-Mar-2018 | Current |
Financial Performance of S. Parikh Pharma.
S. Parikh Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.01% decrease. The company also saw a slight decrease in profitability, with a 8.93% decrease in profit. The company's net worth Soared by an impressive increase of 17.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of S. Parikh Pharma?
In 2023, S. Parikh Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Suparshva Pharma Private LimitedActive 14 years 6 monthsAnkit Shah, Bhaumik Shah and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 16 Dec 2016 | ₹10.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 16 Dec 2016 | ₹1.60 Cr | Open |
Vasai Vikas Sahakari Bank Ltd Creation Date: 16 Jun 2012 | ₹4.50 Cr | Satisfied |
How Many Employees Work at S. Parikh Pharma?
S. Parikh Pharma has a workforce of 77 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S. Parikh Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S. Parikh Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
